Athina Mavrou
Affiliations: | 2010-2013 | University of Bristol, Bristol, England, United Kingdom |
Google:
"Athina Mavrou"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mavrou A, Oltean S. (2016) SRPK1 inhibition in prostate cancer: a novel anti-angiogenic treatment through modulation of VEGF alternative splicing. Pharmacological Research |
| Mavrou A, Brakspear K, Hamdollah-Zadeh M, et al. (2014) Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. Oncogene |
| Mavrou A, Bates D, Oltean S. (2014) Abstract 2749: SRPK1 inhibition and modulation of VEGF alternative splicing as a potential therapeutic strategy in prostate cancer Cancer Research. 74: 2749-2749 |
| Bates DO, Mavrou A, Qiu Y, et al. (2013) Detection of VEGF-A(xxx)b isoforms in human tissues. Plos One. 8: e68399 |
| Mavrou A, Oltean S, Bates D. (2013) Abstract 380: Serine-Arginine protein kinase 1 (SRPK1) - A potential target of angiogenesis in prostate cancer. Cancer Research. 73: 380-380 |
| Oltean S, Gammons M, Hulse R, et al. (2012) SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases. Biochemical Society Transactions. 40: 831-5 |
| Oltean S, Neal CR, Mavrou A, et al. (2012) VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice. American Journal of Physiology. Renal Physiology. 303: F1026-36 |